David Loebenberg

6.6k citations
109 papers · 5.5k · 1 hit paper · h-index 34

Impact in

    • Antifungal resistance and susceptibility
  • Epidemiology top 0.5%
    • Fungal Infections and Studies
    • Pneumocystis jirovecii pneumonia detection and treatment
    • Trypanosoma species research and implications
    • Nail Diseases and Treatments

Papers in

    • Antifungal resistance and susceptibility 41
    • Microbial Natural Products and Biosynthesis 23
    • Fungal Biology and Applications 19
    • Antibiotics Pharmacokinetics and Efficacy 8

David Loebenberg

104 papers receiving 5.2k citations

David Loebenberg's Hit Papers

Nonfilamentous C. albicans Mutants Are Avirulent 1997 · 1.5k citations
1.5k0+9+19Years since publication50010001.5k

Peers

David Loebenberg
Comparison fields: 5 of 115
  • Infectious Diseases 3.6k
  • Epidemiology 2.9k
  • Small Animals 504
  • Pharmacology 790
  • Microbiology 151
Replace R S Hare with:
R S Hare United States
G S Kobayashi United States
Ana Espinel‐Ingroff United States
J. Van Cutsem Belgium
Ken Haynes United Kingdom
Joseph Meletiadis Greece
Karen Joy Shaw United States
William R. Kirkpatrick United States
Ana Alastruey‐Izquierdo Spain
Richard Calderone United States
David Loebenberg relative to R S Hare United States R S Hare's profile →
Citations per field
00.5×1.5×
R S Hare · 1×
Citations per year

Countries citing papers authored by David Loebenberg

Since Specialization
Citations

This map shows the geographic impact of David Loebenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loebenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loebenberg more than expected).

Fields of papers citing papers by David Loebenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Loebenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loebenberg. The network helps show where David Loebenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside David Loebenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Loebenberg Line = papers co-authored together David Loebenberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nonfilamentous C. albicans Mutants Are Avirulent
Hit paper breakdown →
19971540
2 2006378
3 2004219
4 2003159
5 2004156
6 2000156
7 2002155
8 2003144
9 1998137
10 2003126
11 2001104
12 200090
13 200189
14 200578
15 199878
16 200470
17 199967
18 199965
19 198164
20 200061

About David Loebenberg

David Loebenberg is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Molecular Biology and Organic Chemistry, having authored 109 papers that have together received 5.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (41 papers), Microbial Natural Products and Biosynthesis (23 papers), Fungal Infections and Studies (19 papers), Fungal Biology and Applications (19 papers), Marine Sponges and Natural Products (12 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Plant Pathogens and Fungal Diseases (7 papers) and Helminth infection and control (7 papers). The work is most often cited by research in Infectious Diseases (3.6k citations), Epidemiology (2.9k citations), Small Animals (504 citations), Pharmacology (790 citations) and Microbiology (151 citations). David Loebenberg has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Anthony Cacciapuoti, Beth DiDomenico, Gerald R. Fink, Julia R. Köhler, Hsiu‐Jung Lo, Paul M. McNicholas, R S Hare, John R. Graybill, Cara Mendrick and Laura K. Najvar. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Journal of Antimicrobial Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact